ongyyy
赞了
ongyyy
赞了
$Luminar Technologies (LAZR.US)$ announced the upsizing and completion of their convertible notes offering, which they plan to use for an increased share buyback program.
The company, which is developing lidar-based self driving software and sensors, announced the deal for 1.25% convertible notes was fully subscribed including an upsizing for $625M in gross proceeds. Luminar had previously estimated that this would lead to $608M in net proceeds. The company "expects to use over $300 million of the proceeds for $Luminar Technologies (LAZR.US)$ share purchases," having previously announced plans to buy "$250M or more" of shares.
“We have more conviction than ever in our market leadership and business trajectory, and are opportunistically capitalizing on what we believe to be a substantially undervalued and volatile share price,” said Tom Fennimore, Chief Financial Officer of Luminar in the press release.
Beyond the share repurchase plan, the company plans to use the net proceeds to invest in series production capacity expansion, new commercial wins, technology roadmap advancement, international expansion, and accelerating software development, and said it remains on track to enter the series production phase by the end of 2022.
Luminar shares are up 2.8% today amidst a buoyant day for electric vehicle related companies, with $特斯拉 (TSLA.US)$ up 4.9%, $Nikola (NKLA.US)$ up 16%, and Nio $蔚来 (NIO.US)$ up 2.1%. The share buyback news comes just over a year after Luminar came public via a SPAC merger, and with shares down nearly 50% for the year. The company has grown revenues this year but has yet to turn a gross profit and has seen widening operating and net losses, a reminder of its early stage nature.
The company, which is developing lidar-based self driving software and sensors, announced the deal for 1.25% convertible notes was fully subscribed including an upsizing for $625M in gross proceeds. Luminar had previously estimated that this would lead to $608M in net proceeds. The company "expects to use over $300 million of the proceeds for $Luminar Technologies (LAZR.US)$ share purchases," having previously announced plans to buy "$250M or more" of shares.
“We have more conviction than ever in our market leadership and business trajectory, and are opportunistically capitalizing on what we believe to be a substantially undervalued and volatile share price,” said Tom Fennimore, Chief Financial Officer of Luminar in the press release.
Beyond the share repurchase plan, the company plans to use the net proceeds to invest in series production capacity expansion, new commercial wins, technology roadmap advancement, international expansion, and accelerating software development, and said it remains on track to enter the series production phase by the end of 2022.
Luminar shares are up 2.8% today amidst a buoyant day for electric vehicle related companies, with $特斯拉 (TSLA.US)$ up 4.9%, $Nikola (NKLA.US)$ up 16%, and Nio $蔚来 (NIO.US)$ up 2.1%. The share buyback news comes just over a year after Luminar came public via a SPAC merger, and with shares down nearly 50% for the year. The company has grown revenues this year but has yet to turn a gross profit and has seen widening operating and net losses, a reminder of its early stage nature.
2
ongyyy
赞了
目前,Wood和她的颠覆性愿景正在面临巨大考验。旗舰基金ARKInnovation ETF(ARKK)刚刚创出2月份以来最差单周表现,下跌12.7%至一年多来最低水平。该公司8种策略中的6种在2021年录得下跌,其中表现最差的是 $ARK生物基因科技革新主动型ETF (ARKG.US)$ ,跌幅达37%。ARKK在纽约市场开盘一度下跌4.8%,收盘时收复失地,上涨1.5%。该基金今年以来下跌近24%。
①ARK系列主动型ETF当日共操作7笔,其中买入5只股票,卖出2只股票。
② $ARK Fintech Innovation ETF (ARKF.US)$ 和 $ARK Innovation ETF (ARKK.US)$ 加仓 $Signify Health (SGFY.US)$ 是领先的医疗保健平台,它利用先进的分析,技术和全国性的医疗保健提供商网络来创建和支持基于价值的支付程序。
3ARKK加仓 $Teladoc Health (TDOC.US)$ ,Teladoc是一家远距照护公司,通过移动装置、网络、视讯及电话提供随选保健。其解决方案由医师、保健专业人员、医疗服务提供者与用户直接连接,提供大范围的急性诊断,例如上呼吸道感染、泌尿道感染、鼻窦炎、皮肤病、焦虑、戒烟等状况及个案。
④ARKK卖出 $Editas Medicine (EDIT.US)$,Editas
Medicine是一家基因组编辑公司。该公司通过修正致病基因治疗遗传疾病。
①ARK系列主动型ETF当日共操作7笔,其中买入5只股票,卖出2只股票。
② $ARK Fintech Innovation ETF (ARKF.US)$ 和 $ARK Innovation ETF (ARKK.US)$ 加仓 $Signify Health (SGFY.US)$ 是领先的医疗保健平台,它利用先进的分析,技术和全国性的医疗保健提供商网络来创建和支持基于价值的支付程序。
3ARKK加仓 $Teladoc Health (TDOC.US)$ ,Teladoc是一家远距照护公司,通过移动装置、网络、视讯及电话提供随选保健。其解决方案由医师、保健专业人员、医疗服务提供者与用户直接连接,提供大范围的急性诊断,例如上呼吸道感染、泌尿道感染、鼻窦炎、皮肤病、焦虑、戒烟等状况及个案。
④ARKK卖出 $Editas Medicine (EDIT.US)$,Editas
Medicine是一家基因组编辑公司。该公司通过修正致病基因治疗遗传疾病。
15
3
ongyyy
赞了
$亚洲付费电视信托 (S7OU.SG)$ great for regular quarterly dividends. current level at 7% per annum
11